vialroom

#semaglutide 2024-07-24

Wednesday36 messages8 participantstimes are UTC
Highlights from this day
  • area_percent — while im here i dont think the plateau is a dose problem most of the time, but i cant prove that 17:26
  • a1c_lag — the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing, anyway 18:24
  • mg_per_ml — did anyone titrate slower than four weeks a step and how did that go 19:18
  • abdo_two_inch — unrelated but my plateau was the scale stopping while appetite stayed suppressed, which is a different problem 19:37
  • area_percent — my Janoshik report on the KP vial came back 99.4 against a certificate saying 97.4 20:14
AP

while im here i dont think the plateau is a dose problem most of the time, but i cant prove that

💀112🔥1
MW

is the plateau at 20 weeks normal or am i doing something wrong

went too fast once

AP

the appetite effect faded for me around 22 months and going up fixed it for a while

half life is about a week so youre roughly four to five weeks to steady state on any new dose

AP

went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down

LM

vial units and pen clicks are different systems, mixing the two is how people end up wrong

MP

my 5 vial in 1.5ml gives 2mg/ml so 1.7 lands on 20 units, thats why i picked that volume

MP

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step
i held at 0.5 for 8 months and it was the best decision i made

AP

while im here SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

MP

genuine question did anyone hold at 2.4 longer than four weeks before going up

MP

give it four weeks

Cited study
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT)
New England Journal of Medicine · 2023
Hard cardiovascular endpoints in people with overweight or obesity and established disease.
MP

did anyone titrate slower than four weeks a step and how did that go

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
LM

18 months at 2.4 and the honest summary is diminishing returns after the first half
compounded and brand felt the same to me at 2.4, which is one person and nothing more

AP

my dose day drifted from friday to sunday, does that reset anything

ST

going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution

AT

unrelated but my plateau was the scale stopping while appetite stayed suppressed, which is a different problem

🤝15📉18

i stayed on 1.7 for 18 months and never went to 2.4, appetite was already where i needed it

AP

my Janoshik report on the KP vial came back 99.4 against a certificate saying 97.4

[edited]
AT

STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping

[edited]
TF

not the same trial

Cited study
Effect of Semaglutide Coadministered with Intensive Behavioural Therapy (STEP 3)
JAMA · 2021
Semaglutide plus intensive behavioural therapy and a low-calorie diet run-in.

same dose day

TF

five week steps worked better for me than four, purely on how the second week felt, happy to be corrected

🙏3

the plateau hit me at 3 weeks and moved again about a month later without a dose change